Clinical Trials
171 trialsClinical Significance of Hepatic and Circulating microRNAs miR-221 and miR-222 in Hepatocellular Carcinoma
University of Aberdeen
Extracellular RNA Markers of Liver Disease and Cancer
Mayo Clinic
NOLA (NeuWave Observational Liver Ablation) Registry
Ethicon, Inc.
Molecular and Epidemiological Risk Factors in the Development of Gastric Cancer
The University of Texas Health Science Center at San Antonio
CLEAR
Harbinger Health
Comparison Between Robotic and Laparoscopic Right Hemicolectomy
Sir Run Run Shaw Hospital
ExoColon
Centre Hospitalier Universitaire Dijon
Neo-Flo-Rect
Centre Oscar Lambret
PLATON
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Clinical Utility of Selected Circulating Tumor DNA Assays in Patients With Advanced Malignancy
Oslo University Hospital
Liver and Biliary Tumor Tissue Registry
Mayo Clinic
IMMUNOCELL
Assistance Publique - Hôpitaux de Paris
Informed Choice - Compass
Exact Sciences Corporation
YASU Research Registry: For Young Adults With Cancer
Young Adult Survivors United
Genetic Testing in Screening Patients With Metastatic or Unresectable Colon or Rectal Cancer for a COLOMATE Trial
Academic and Community Cancer Research United
HLA Typing & Tumor Neoantigen Identification for Phase I/II Study of Autologous TCR-T Cells in Subjects With Solid Tumors
Alaunos Therapeutics
ISTAR-04
Seoul National University Hospital
Feasibility Study of Multi-Platform Profiling of Resected Biliary Tract Cancer
University of Washington
Single Nucleotide Polymorphism(SNP)Study. ICORG 08-40, V4
Cancer Trials Ireland
Plasma Biomarkers C-RAC, ICORG 12-27, V1
Cancer Trials Ireland
STOP-HCC
Johns Hopkins University
Transnasal Esophagoscopy (TNE) Esophageal Cancer Screening
University of Illinois at Chicago
CHIMIOSE
University Hospital, Lille
Diagnostic Accuracy of SurePathâ„¢ in EUS-FNA
Seoul National University Hospital
EQLVCPAL
Centre Hospitalier de la côte Basque
PROSPECT-ESO
Bristol-Myers Squibb
Observational Familial Adenomatous Polyposis Registry Study In Patients Receiving Celecoxib Compared to Control Patients
Pfizer
The CHOICE Registry
Taiho Oncology, Inc.
Detection of MSI in Circulating Tumor DNA of Colorectal Carcinoma Patients
University of Southern California
Food Reward in Cachexia Induced by Acute or Chronic Disease
Maastricht University Medical Center
Yttrium-90 (TARE-Y90) in Children, Adolescents, and Young Adults With Liver Tumors
Nemours Children's Clinic
PSC-LCNA
Anhui Medical University
Early Detection of Esophageal Cancer
National Institutes of Health Clinical Center (CC)
NORWAIT
Helse Stavanger HF
e:Med-HCC-2
University Hospital Tuebingen
REWARD
Imperial College London
Measuring Cell Free DNA During the Course of Treatment for Esophageal Cancer as a Marker of Response and Recurrence
Mayo Clinic
ARRAY
Focused Ultrasound Foundation
INST 0603C Patients With Unresectable/Metastatic Pancreatic Cancer Treated in the UNM Cancer
University of New Mexico
Chart Review: Unresectable/Metastatic Cholangiocarcinoma Treated With Irinotecan, Capecitabine and Celecoxib
University of New Mexico
iEXMachyna3
IHU Strasbourg
PreColo CU
Radboud University Medical Center
Systems Biology of Gastrointestinal and Related Diseases
Viome
Utilization of MAsS in Patients Undergoing LT for HCC
Columbia University
HSL2012-06
Hospital Sirio-Libanes
RadPFD
Wake Forest University Health Sciences
Safety and Efficacy of Lenvatinib in Subjects With HCC Progression After First Line Treatment With Checkpoint Inhibitors
Humanity & Health Medical Group Limited
Long-term, Non-interventional, Observational Study Following Treatment With Fate Therapeutics FT500 Cellular Immunotherapy
Fate Therapeutics
Colorectal Screening Strategies in Underserved Populations
Virtua Health, Inc.
Metastatic Colorectal Cancer: Treatment Response With Dynamic Contrast MRI
American College of Radiology